Neopharm Ltd Stock Beneish M Score

092730 Stock  KRW 11,950  10.00  0.08%   
This module uses fundamental data of NeoPharm to approximate the value of its Beneish M Score. NeoPharm M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in NeoPharm LTD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
  
At this time, NeoPharm's M Score is inapplicable. The earnings manipulation may begin if NeoPharm's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by NeoPharm executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of NeoPharm's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-4.84
Beneish M Score - Inapplicable
Elasticity of Receivables

N/A

Focus
Asset Quality

N/A

Focus
Expense Coverage

N/A

Focus
Gross Margin Strengs

N/A

Focus
Accruals Factor

N/A

Focus
Depreciation Resistance

N/A

Focus
Net Sales Growth

N/A

Focus
Financial Leverage Condition

N/A

Focus

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

About NeoPharm Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze NeoPharm LTD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeoPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeoPharm LTD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with NeoPharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeoPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoPharm will appreciate offsetting losses from the drop in the long position's value.

Moving against NeoPharm Stock

  0.35054180 MEDICOXPairCorr
  0.34006920 MohenzCoLtdPairCorr
The ability to find closely correlated positions to NeoPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeoPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeoPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeoPharm LTD to buy it.
The correlation of NeoPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoPharm LTD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeoPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in NeoPharm Stock

NeoPharm financial ratios help investors to determine whether NeoPharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NeoPharm with respect to the benefits of owning NeoPharm security.


 

Trending Assets

500003
Shinhan Inverse WTI
2,750  15.00  0.55 
351320
Solution Advanced
1,482  68.00  4.81 
133820
Finebesteel
1,036  33.00  3.29 
011390
Busan Industrial
88,000  11,500  15.03 
000250
Sam Chun Dang
102,000  1,400  1.39 
011390
Busan Ind
88,000  11,500  15.03 
040910
ICD Co
4,535  5.00  0.11 
104460
DYPNF CoLtd
12,660  120.00  0.96 
058400
Korea New Network
900.00  9.00  1.01 
115160
Humax
1,083  33.00  3.14 
News Freq…Investor S…